Skip to main content

Pekin Hardy Strauss, Inc.

Position in LLY — ELI LILLY & Co

CIK 1020317 CHICAGO, IL

Position in LLY

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$1,164,646
+$517,128 QoQ
Shares Held
971
+37.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#2,995
of 4,605 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Sep 30, 2025
CallValue
$2,060,100
CallShares
2,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Pekin Hardy Strauss, Inc. holds $25,845,902 across 12 Drug Manufacturers - General names. LLY ranks #7 (4.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 LLY
ELI LILLY & Co
This page
971 $1,164,646

All Filings in LLY

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,164,646 971
2026-03-31 $647,518 704
2025-12-31 $731,857 681
2025-09-30 $2,060,100 2,700
2025-09-30 $529,522 694
2025-06-30 $502,017 644
2025-06-30 $1,948,825 2,500
2025-03-31 $1,899,593 2,300
2025-03-31 $519,497 629
2024-12-31 $531,136 688
2024-09-30 $1,360,803 1,536
2024-06-30 $1,227,695 1,356
2024-03-31 $953,778 1,226
2023-12-31 $751,966 1,290
2023-09-30 $685,915 1,277
2023-06-30 $505,091 1,077
2023-03-31 $282,634 823
2022-12-31 $410,838 1,123
2022-09-30 $359,888 1,113
2022-06-30 $346,926 1,070
2022-03-31 $286,942 1,002
2021-12-31 $276,772 1,002
2021-09-30 $254,617 1,102
2021-06-30 $229,979 1,002